250 related articles for article (PubMed ID: 33672651)
1. A Multi-Omics Study Revealing the Metabolic Effects of Estrogen in Liver Cancer Cells HepG2.
Shen M; Xu M; Zhong F; Crist MC; Prior AB; Yang K; Allaire DM; Choueiry F; Zhu J; Shi H
Cells; 2021 Feb; 10(2):. PubMed ID: 33672651
[TBL] [Abstract][Full Text] [Related]
2. Effects of Estrogen and Estrogen Receptors on Transcriptomes of HepG2 Cells: A Preliminary Study Using RNA Sequencing.
Shen M; Cao J; Shi H
Int J Endocrinol; 2018; 2018():5789127. PubMed ID: 30510575
[TBL] [Abstract][Full Text] [Related]
3. 17β-Estradiol inhibits testosterone-induced cell proliferation in HepG2 by modulating the relative ratios of 3 estrogen receptor isoforms to the androgen receptor.
Xu Z; Liu J; Jianxin C; Yongliang Z; Pan X
J Cell Biochem; 2018 Nov; 119(10):8659-8671. PubMed ID: 30058741
[TBL] [Abstract][Full Text] [Related]
4. Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells.
Shen M; Shi H
PLoS One; 2016; 11(3):e0151455. PubMed ID: 26982332
[TBL] [Abstract][Full Text] [Related]
5. The effects of estrogen receptors α- and β-specific agonists and antagonists on cell proliferation and energy metabolism in human bone cell line.
Somjen D; Katzburg S; Sharon O; Grafi-Cohen M; Knoll E; Stern N
J Cell Biochem; 2011 Feb; 112(2):625-32. PubMed ID: 21268084
[TBL] [Abstract][Full Text] [Related]
6. Sex specific response of cultured human bone cells to ERα and ERβ specific agonists by modulation of cell proliferation and creatine kinase specific activity.
Somjen D; Katzburg S; Sharon O; Knoll E; Hendel D; Stern N
J Steroid Biochem Mol Biol; 2011 Jul; 125(3-5):226-30. PubMed ID: 21397017
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 1A2 Metabolizes 17β-Estradiol to Suppress Hepatocellular Carcinoma.
Ren J; Chen GG; Liu Y; Su X; Hu B; Leung BC; Wang Y; Ho RL; Yang S; Lu G; Lee CG; Lai PB
PLoS One; 2016; 11(4):e0153863. PubMed ID: 27093553
[TBL] [Abstract][Full Text] [Related]
8. High dose 17 beta-estradiol and the alpha-estrogen agonist PPT trigger apoptosis in human adrenal carcinoma cells but the beta-estrogen agonist DPN does not.
Prieto LM; Brown JW; Perez-Stable C; Fishman LM
Horm Metab Res; 2008 May; 40(5):311-4. PubMed ID: 18491249
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of mammary tumor growth by estrogens: is there a specific role for estrogen receptors alpha and beta?
Soldati R; Wargon V; Cerliani JP; Giulianelli S; Vanzulli SI; Gorostiaga MA; Bolado J; do Campo P; Molinolo A; Vollmer G; Lanari C
Breast Cancer Res Treat; 2010 Oct; 123(3):709-24. PubMed ID: 20012353
[TBL] [Abstract][Full Text] [Related]
10. Estradiol and testosterone regulate arginine-vasopressin expression in SH-SY5Y human female neuroblastoma cells through estrogen receptors-α and -β.
Grassi D; Bellini MJ; Acaz-Fonseca E; Panzica G; Garcia-Segura LM
Endocrinology; 2013 Jun; 154(6):2092-100. PubMed ID: 23584859
[TBL] [Abstract][Full Text] [Related]
11. Distinct roles of estrogen receptors alpha and beta mediating acute vasodilation of epicardial coronary arteries.
Traupe T; Stettler CD; Li H; Haas E; Bhattacharya I; Minotti R; Barton M
Hypertension; 2007 Jun; 49(6):1364-70. PubMed ID: 17470727
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor (ER) agonists differentially regulate neuroangiogenesis in peritoneal endometriosis via the repellent factor SLIT3.
Greaves E; Collins F; Esnal-Zufiaurre A; Giakoumelou S; Horne AW; Saunders PT
Endocrinology; 2014 Oct; 155(10):4015-26. PubMed ID: 25051436
[TBL] [Abstract][Full Text] [Related]
13. 2-Methoxyestradiol, an endogenous 17β-estradiol metabolite, inhibits microglial proliferation and activation via an estrogen receptor-independent mechanism.
Schaufelberger SA; Rosselli M; Barchiesi F; Gillespie DG; Jackson EK; Dubey RK
Am J Physiol Endocrinol Metab; 2016 Mar; 310(5):E313-22. PubMed ID: 26732685
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-Mesenchymal Transition (EMT) Induced by TGF-β in Hepatocellular Carcinoma Cells Reprograms Lipid Metabolism.
Soukupova J; Malfettone A; Bertran E; Hernández-Alvarez MI; Peñuelas-Haro I; Dituri F; Giannelli G; Zorzano A; Fabregat I
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073989
[TBL] [Abstract][Full Text] [Related]
15. Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) alpha activity by ERbeta in the uterus.
Frasor J; Barnett DH; Danes JM; Hess R; Parlow AF; Katzenellenbogen BS
Endocrinology; 2003 Jul; 144(7):3159-66. PubMed ID: 12810572
[TBL] [Abstract][Full Text] [Related]
16. Dilatory responses to estrogenic compounds in small femoral arteries of male and female estrogen receptor-beta knockout mice.
Cruz MN; Douglas G; Gustafsson JA; Poston L; Kublickiene K
Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H823-9. PubMed ID: 16183727
[TBL] [Abstract][Full Text] [Related]
17. Role of estrogen receptor-alpha and -beta in regulating leptin expression in 3T3-L1 adipocytes.
Yi KW; Shin JH; Seo HS; Lee JK; Oh MJ; Kim T; Saw HS; Kim SH; Hur JY
Obesity (Silver Spring); 2008 Nov; 16(11):2393-9. PubMed ID: 18719660
[TBL] [Abstract][Full Text] [Related]
18. Studies on estrogen receptor (ER) alpha and beta responses on gene regulation in peripheral blood leukocytes in vivo using selective ER agonists.
Stygar D; Masironi B; Eriksson H; Sahlin L
J Endocrinol; 2007 Jul; 194(1):101-19. PubMed ID: 17592025
[TBL] [Abstract][Full Text] [Related]
19. The aspartate metabolism pathway is differentiable in human hepatocellular carcinoma: transcriptomics and (13) C-isotope based metabolomics.
Darpolor MM; Basu SS; Worth A; Nelson DS; Clarke-Katzenberg RH; Glickson JD; Kaplan DE; Blair IA
NMR Biomed; 2014 Apr; 27(4):381-9. PubMed ID: 24497316
[TBL] [Abstract][Full Text] [Related]
20. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L
PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
